Investigators found certain classes of prescriptions were also associated with outcomes, though they do not believe the ...

Atezolizumab enhances long-term outcomes in triple-negative breast cancer, revealing promising insights on ctDNA as a prognostic biomarker.

A public procession will take place in Osbourne's hometown on Wednesday before his family gathers for a small, private ...